$37.74 B
Share price
Change (1 day)
Change (1 year)

Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.

Number of shares outstanding for Biogen (BIIB)

Number of shares outstanding as of March 2023 : 144,100,000

According to Biogen's latest financial reports and stock price the company's current number of shares outstanding is 144,100,000. At the end of 2022 the company had 144,100,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Biogen from 2001 to 2022

Shares Outstanding at the end of each year

Year Shares Outstanding Change
20220.14 B-1.91%
20210.14 B-4.42%
20200.15 B-13.55%
20190.17 B-11.01%
20180.19 B-5.53%
20170.21 B-2.35%
20160.21 B-1.72%
20150.22 B-6.4%
20140.23 B-0.34%
20130.23 B-0.14%
20120.23 B-2.61%
20110.24 B1.29%
20100.23 B-16.98%
20090.28 B-0.85%
20080.29 B0.85%
20070.28 B-14.51%
20060.33 B0.44%
20050.33 B0.53%
20040.33 B122.99%
20030.15 B0.41%
20020.14 B0.75%
20010.14 B

Shares Outstanding for similar companies or competitors

Company Shares Outstanding differencediff. Country
2,627,900,000 1,723.66%๐Ÿ‡บ๐Ÿ‡ธ USA
5,607,000,000 3,791.05%๐Ÿ‡บ๐Ÿ‡ธ USA
1,769,181,294 1,127.75%๐Ÿ‡บ๐Ÿ‡ธ USA
535,000,000 271.27%๐Ÿ‡บ๐Ÿ‡ธ USA
2,507,000,000 1,639.76%๐Ÿ‡ซ๐Ÿ‡ท France
1,255,000,000 770.92%๐Ÿ‡บ๐Ÿ‡ธ USA
157,000,000 8.95%๐Ÿ‡บ๐Ÿ‡ธ USA
24,290,000-83.14%๐Ÿ‡บ๐Ÿ‡ธ USA
227,716,000 58.03%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
29,683,000-79.40%๐Ÿ‡บ๐Ÿ‡ธ USA